Development of a Targeted Patient Portal Intervention to Improve Depression Treatment Adherence and Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-31

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to learn how best to use patient portals to help improve the treatment of mood disorders.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Megastudy of Single-Session Interventions for Depression

NCT06856668

Depression - Major Depressive Disorder

COMPLETED NA

Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method

NCT07028216

Anxiety Disorders Generalized Anxiety Disorder Social Anxiety Disorder +4 more

RECRUITING NA

Brief Video Interventions for Depression

NCT04643964

Depressive Symptoms

COMPLETED NA

Cognitive Control Training as an Adjunct to Behavioral Activation Therapy in the Treatment of Depression

NCT01694719

Depression

UNKNOWN NA

Novel Neural Circuit Biomarkers of Major Depression Response to CCBT

NCT03096886

Depression Major Depressive Disorder Depressive Disorder +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is being done in 3 phases. First 2 phases were observational with total enrollment of 300 subjects. The final 3rd phase is interventional and we are anticipating to enroll 50 subjects. It is described below.

Patients being treated for depressive symptoms at the University of Iowa, Department of Psychiatry are invited to participate. Participants will complete a remote (phone or video) visit. After being informed about the study and potential risks, those who consent to being in the study will be assigned to one of two groups. They will complete an online survey and receive some basic training on patient portals. After the visit. both groups will be followed for 6 months. Depending on their group assignment, they will complete:

* two to five phone calls with a study team member and
* two to five online questionnaires

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Group Type EXPERIMENTAL

ConnectCare

Intervention Type BEHAVIORAL

increased monitoring between clinical mental health visits

Group 2

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ConnectCare

increased monitoring between clinical mental health visits

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* English speaking,
* PHQ-9 score of 10 or higher (questions 1-8 only),
* Taking medication for depressive symptoms,
* 1 or more appointments scheduled or planned with University of Iowa psychiatry provider in next 6 months,
* Home computer w/internet access,
* MyChart (University of Iowa Healthcare's patient portal) account/MyChart enrollment

Exclusion Criteria

* Psychotic disorder/symptoms,
* Current substance use disorders (other than alcohol, tobacco, marijuana),
* Active suicidal ideation within past 1 year,
* Cognitive impairment

Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No